Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Selenium as a Potential Treatment for Moderately-ill, Severely-ill, and Critically-ill COVID-19 Patients. (SeCOVID)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04869579
Recruitment Status : Not yet recruiting
First Posted : May 3, 2021
Last Update Posted : May 5, 2021
Sponsor:
Collaborator:
Pharco Pharmaceuticals
Information provided by (Responsible Party):
Mohamed Ghoweba, MD, CHRISTUS Health

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : September 1, 2021
Estimated Study Completion Date : October 1, 2021
Publications: